Phase I Trial: Cirmtuzumab Inhibits ROR1 Signaling and...

Cell Stem Cell 2018 / 06 Vol. 22; Iss. 6

Phase I Trial: Cirmtuzumab Inhibits ROR1 Signaling and Stemness Signatures in Patients with Chronic Lymphocytic Leukemia

Choi, Michael Y., Widhopf, George F., Ghia, Emanuela M., Kidwell, Reilly L., Hasan, Md Kamrul, Yu, Jian, Rassenti, Laura Z., Chen, Liguang, Chen, Yun, Pittman, Emily, Pu, Minya, Messer, Karen, Prussak
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
22
Language:
english
Journal:
Cell Stem Cell
DOI:
10.1016/j.stem.2018.05.018
Date:
June, 2018
File:
PDF, 2.08 MB
english, 2018
Conversion to is in progress
Conversion to is failed